1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
US5646140A · kind A · utility
45Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 1995 |
| Grant date | Jul 8, 1997 |
| Priority date | — |
| Expiry date | Oct 13, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to novel benzodiazepine compounds of formula (I) ##STR1## which exhibit agonistic activity for CCK-A receptors, enabling them to modulate the hormones gastrin and cholecystokinin (CCK) in mammals for use in medicine as anorectic agents in the regulation of appetite, the treatment of obesity and the maintenance of weight loss.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.